Thalassemic osteopathy: A new marker of bone deposition

Skordis, 2011, Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects, Pediatr. Endocrinol. Rev., 8, 300 Perisano, 2012, Physiopathology of bone modifications in beta-thalassemia, Anemia, 2012, 320737, 10.1155/2012/320737 Scacchi, 2008, Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites, Clin. Endocrinol. (Oxf), 69, 202, 10.1111/j.1365-2265.2008.03191.x Mahachoklertwattana, 2003, Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia, J. Clin. Endocrinol. Metab., 88, 3966, 10.1210/jc.2002-021548 Lombardi, 2012, Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling, Clin. Chem. Lab. Med., 50, 771, 10.1515/cclm-2011-0614 Hannon, 1998, Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability, J. Bone Miner. Res., 13, 1124, 10.1359/jbmr.1998.13.7.1124 Peris, 1999, Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy, Bone, 25, 349, 10.1016/S8756-3282(99)00175-1 Alvarez, 1997, Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity, Arthritis Rheum., 40, 461, 10.1002/art.1780400312 Scariano, 2002, Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density, Scand. J. Clin. Lab. Invest., 62, 237, 10.1080/003655102317475506 Eastell, 2006, Development of an algorithm for using PINP to monitor treatment of patients with teriparatide, Curr. Med. Res. Opin., 22, 61, 10.1185/030079905X75096 Alvarez, 2000, Components of biological variation of biochemical markers of bone turnover in Paget's bone disease, Bone, 26, 571, 10.1016/S8756-3282(00)00279-9 Alvarez, 2001, Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease, Bone, 29, 447, 10.1016/S8756-3282(01)00592-0 Chatterjee, 2012, Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteopenia–osteoporosis syndrome, Br. J. Haematol., 159, 462, 10.1111/bjh.12048 Pagani, 2005, Markers of bone turnover: biochemical and clinical perspectives, J. Endocrinol. Invest., 28, 8 Seibel, 2001, Interlaboratory variation of biochemical markers of bone turnover, Clin. Chem., 47, 1443, 10.1093/clinchem/47.8.1443 Havill, 2006, QTL with pleiotropic effects on serum levels of bone-specific alkaline phosphatase and osteocalcin maps to the baboon ortholog of human chromosome 6p23-21.3, J. Bone Miner. Res., 21, 1888, 10.1359/jbmr.060812 Knapen, 1998, Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10years after menopause, Calcif. Tissue Int., 63, 375, 10.1007/s002239900543 Kleerekoper, 1996, Biochemical markers of bone remodeling, Am. J. Med. Sci., 31, 270, 10.1097/00000441-199612000-00005 Riis, 1993, Biochemical markers of bone turnover. II: diagnosis, prophylaxis, and treatment of osteoporosis, Am. J. Med., 95, 17S, 10.1016/0002-9343(93)90376-Z Melkko, 1996, Immunoassay for intact amino-terminal propeptide of human type I procollagen, Clin. Chem., 42, 947, 10.1093/clinchem/42.6.947 Vasikaran, 2012, The role of the laboratory in investigation and management of bone disease, Clin. Biochem., 45, 861, 10.1016/j.clinbiochem.2012.05.028 Vasikaran, 2011, Recommendations for bone marker standards in osteoporosis: what, why and where to now?, Ann. Clin. Biochem., 48, 91, 10.1258/acb.2011.010286